Tag: Menopause / Postmenopause
Postmenopausal Women Have Higher Risk for Developing Rheumatoid Arthritis
Risk nearly tripled for women who experience menopause before 45 years of age
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
Early Bilateral Oophorectomy Increases Risk of Alzheimer Disease
Risk even higher among women with bilateral oophorectomy carrying an APOE4 allele
Weaker Handgrip Strength Tied to Higher Likelihood of Diabetes
Findings seen among postmenopausal women; association stronger in those postmenopausal for >10 years
Tibolone, Oral Estrogen-Progestin Therapy Linked to Risk for Heart Disease
Risk for ischemic heart disease elevated for initiators of tibolone or oral estrogen-progestin therapy
No Long-Term Cognitive Effects Seen for Menopausal Hormone Therapy
No long-term cognitive effects of mHT were seen in the KEEPS Continuation study, about 10 years after completion of randomized treatment
Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes
Women with persistently high VMS have increased risk for diabetes versus those with persistently low VMS
ACG: Hormone Therapy Tied to Higher Risk for New Irritable Bowel Syndrome
Hormone replacement therapy also tied to elevated gastrointestinal symptoms and diagnostic testing
Lower Risk for Asthma Seen With Younger Age at Natural Menopause
Hazard ratio of 0.70 reported for risk for asthma with age at natural menopause of 40 to 44 versus 50 to 54 years
Primary Care EHRs Fail to Capture Extent of Menopause Symptoms
Additionally, vasomotor symptoms remain undertreated
